Journal of Otolaryngology and Ophthalmology of Shandong University ›› 2022, Vol. 36 ›› Issue (2): 133-138.doi: 10.6040/j.issn.1673-3770.0.2021.078

Previous Articles     Next Articles

Research progress on the relationship between obstructive sleep apnea-hypopnea syndrome and dyslipidemia

YANG Xijun1, GUAN Jian2,WU Haiying1   

  1. 1. Department of Otorhinolaryngology & Head and Neck Surgery, The Second Affiliated Hospital of Kunming Medical University, Kunming 650101, Yunnan, China;
    2. Department of Otorhinolaryngology & Head and Neck Surgery, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai 200233, China
  • Published:2022-04-15

PDF (PC)

139

Abstract: Obstructive sleep apnea-hypopnea syndrome(OSAHS)is a common sleep apnea disorder. Both OSAHS and lipid metabolism disorders are important chronic conditions affecting human health, and they are closely related to the development of cardiovascular and cerebrovascular diseases. This article will review the possible pathophysiological mechanisms underlying the effect of OSAHS on dyslipidemia and the progress of related clinical research.

Key words: Sleep apnea-hypopnea syndrome, Dyslipidemia, Intermittent hypoxia, Sleep fragmentation, Lipoproteins

CLC Number: 

  • R766.7
[1] Dempsey JA, Veasey SC, Morgan BJ, et al. Pathophysiology of sleep apnea[J]. Physiol Rev, 2010, 90(1): 47-112. doi:10.1152/physrev.00043.2008.
[2] Benjafield AV, Ayas NT, Eastwood PR, et al. Estimation of the global prevalence and burden of obstructive sleep apnoea: a literature-based analysis[J]. Lancet Respir Med, 2019, 7(8): 687-698. doi:10.1016/s2213-2600(19)30198-5.
[3] Fu Y, Xia Y, Yi H, et al. Meta-analysis of all-cause and cardiovascular mortality in obstructive sleep apnea with or without continuous positive airway pressure treatment[J]. Sleep Breath, 2017, 21(1): 181-189. doi:10.1007/s11325-016-1393-1.
[4] Murphy AM, Thomas A, Crinion SJ, et al. Intermittent hypoxia in obstructive sleep apnoea mediates insulin resistance through adipose tissue inflammation[J]. Eur Respir J, 2017, 49(4): 160-173. doi:10.1183/13993003.01731-2016.
[5] Newman AB, Nieto FJ, Guidry U, et al. Relation of sleep-disordered breathing to cardiovascular disease risk factors: the Sleep Heart Health Study[J]. Am J Epidemiol, 2001, 154(1): 50-59. doi:10.1093/aje/154.1.50.
[6] Svatikova A, Wolk R, Gami AS, et al. Interactions between obstructive sleep apnea and the metabolic syndrome[J]. Curr Diab Rep, 2005, 5(1): 53-58. doi:10.1007/s11892-005-0068-2.
[7] Trzepizur W, Le Vaillant M, Meslier N, et al. Independent association between nocturnal intermittent hypoxemia and metabolic dyslipidemia[J]. Chest, 2013, 143(6): 1584-1589. doi:10.1378/chest.12-1652.
[8] Perry JC, D'Almeida V, Souza FG, et al. Consequences of subchronic and chronic exposure to intermittent hypoxia and sleep deprivation on cardiovascular risk factors in rats[J]. Respir Physiol Neurobiol, 2007, 156(3): 250-258. doi:10.1016/j.resp.2006.10.004.
[9] Li JG, Savransky V, Nanayakkara A, et al. Hyperlipidemia and lipid peroxidation are dependent on the severity of chronic intermittent hypoxia[J]. J Appl Physiol Bethesda Md, 2007, 102(2): 557-563. doi:10.1152/japplphysiol.01081.2006.
[10] Li JG, Thorne LN, Punjabi NM, et al. Intermittent hypoxia induces hyperlipidemia in lean mice[J]. Circ Res, 2005, 97(7): 698-706. doi:10.1161/01.RES.0000183879.60089.a9.
[11] Li JG, Nanayakkara A, Jun J, et al. Effect of deficiency in SREBP cleavage-activating protein on lipid metabolism during intermittent hypoxia[J]. Physiol Genomics, 2007, 31(2): 273-280. doi:10.1152/physiolgenomics.00082.2007.
[12] Ntambi JM, Miyazaki M. Regulation of stearoyl-CoA desaturases and role in metabolism[J]. Prog Lipid Res, 2004, 43(2): 91-104. doi:10.1016/s0163-7827(03)00039-0.
[13] Li JG, Bosch-Marce M, Nanayakkara A, et al. Altered metabolic responses to intermittent hypoxia in mice with partial deficiency of hypoxia-inducible factor-1alpha[J]. Physiol Genomics, 2006, 25(3): 450-457. doi:10.1152/physiolgenomics.00293.2005.
[14] Savransky V, Jun J, Li JG, et al. Dyslipidemia and atherosclerosis induced by chronic intermittent hypoxia are attenuated by deficiency of stearoyl coenzyme A desaturase[J]. Circ Res, 2008, 103(10): 1173-1180. doi:10.1161/CIRCRESAHA.108.178533.
[15] Choi SH, Ginsberg HN. Increased very low density lipoprotein(VLDL)secretion, hepatic steatosis, and insulin resistance[J]. Trends Endocrinol Metab, 2011, 22(9): 353-363. doi:10.1016/j.tem.2011.04.007.
[16] Jun J, Reinke C, Bedja D, et al. Effect of intermittent hypoxia on atherosclerosis in apolipoprotein E-deficient mice[J]. Atherosclerosis, 2010, 209(2): 381-386. doi:10.1016/j.atherosclerosis.2009.10.017.
[17] Weiszenstein M, Shimoda LA, Koc M, et al. Inhibition of lipolysis ameliorates diabetic phenotype in a mouse model of obstructive sleep apnea[J]. Am J Respir Cell Mol Biol, 2016, 55(2): 299-307. doi:10.1165/rcmb.2015-0315oc.
[18] Xiong YL, Qu Z, Chen N, et al. The local corticotropin-releasing hormone receptor 2 signalling pathway partly mediates hypoxia-induced increases in lipolysis via the cAMP-protein kinase A signalling pathway in white adipose tissue[J]. Mol Cell Endocrinol, 2014, 392(1/2): 106-114. doi:10.1016/j.mce.2014.05.012.
[19] Kirby DA, Pinto JM, Weiss JW, et al. Effects of beta adrenergic receptor blockade on hemodynamic changes associated with obstructive sleep apnea[J]. Physiol Behav, 1995, 58(5): 919-923. doi:10.1016/0031-9384(95)00150-h.
[20] Roberts AC, Butterfield GE, Cymerman A, et al. Acclimatization to 4, 300-m altitude decreases reliance on fat as a substrate[J]. J Appl Physiol(1985), 1996, 81(4): 1762-1771. doi:10.1152/jappl.1996.81.4.1762.
[21] Pilz S, Scharnagl H, Tiran B, et al. Elevated plasma free fatty acids predict sudden cardiac death: a 6.85-year follow-up of 3315 patients after coronary angiography[J]. Eur Heart J, 2007, 28(22): 2763-2769. doi:10.1093/eurheartj/ehm343.
[22] Pulawa LK, Jensen DR, Coates A, et al. Reduction of plasma triglycerides in apolipoprotein C-II transgenic mice overexpressing lipoprotein lipase in muscle[J]. J Lipid Res, 2007, 48(1): 145-151. doi:10.1194/jlr.M600384-JLR200.
[23] Luyster FS, Kip KE, Drumheller OJ, et al. Sleep apnea is related to the atherogenic phenotype, lipoprotein subclass B[J]. J Clin Sleep Med, 2012, 8(2): 155-161. doi:10.5664/jcsm.1768.
[24] Drager LF, Li J, Shin MK, et al. Intermittent hypoxia inhibits clearance of triglyceride-rich lipoproteins and inactivates adipose lipoprotein lipase in a mouse model of sleep apnoea[J]. Eur Heart J, 2012, 33(6): 783-790. doi:10.1093/eurheartj/ehr097.
[25] Yao QL, Shin MK, Jun JC, et al. Effect of chronic intermittent hypoxia on triglyceride uptake in different tissues[J]. J Lipid Res, 2013, 54(4): 1058-1065. doi:10.1194/jlr.M034272.
[26] Ekstedt M, Akerstedt T, Söderström M. Microarousals during sleep are associated with increased levels of lipids, cortisol, and blood pressure[J]. Psychosom Med, 2004, 66(6): 925-931. doi:10.1097/01.psy.0000145821.25453.f7.
[27] Brindley DN, McCann BS, Niaura R, et al. Stress and lipoprotein metabolism: modulators and mechanisms[J]. Metabolism, 1993, 42(9 Suppl 1): 3-15. doi:10.1016/0026-0495(93)90255-m.
[28] Carreras A, Zhang SX, Peris E, et al. Effect of resveratrol on visceral white adipose tissue inflammation and insulin sensitivity in a mouse model of sleep apnea[J]. Int J Obes(Lond), 2015, 39(3): 418-423. doi:10.1038/ijo.2014.181.
[29] Gündüz C, Basoglu OK, Hedner J, et al. Obstructive sleep apnoea independently predicts lipid levels: Data from the European Sleep Apnea Database[J]. Respirology, 2018, 23(12): 1180-1189. doi:10.1111/resp.13372.
[30] Guan J, Yi HL, Zou JY, et al. Distinct severity stages of obstructive sleep apnoea are correlated with unique dyslipidaemia: large-scale observational study[J]. Thorax, 2016, 71(4): 347-355. doi:10.1136/thoraxjnl-2015-207403.
[31] Bikov A, Lazar Z, Horvath P, et al. Association between serum lipid profile and obstructive respiratory events during REM and non-REM sleep[J]. Lung, 2019, 197(4): 443-450. doi:10.1007/s00408-019-00195-7.
[32] Xu HJ, Xia YY, Li XY, et al. Association between obstructive sleep apnea and lipid metabolism during REM and NREM sleep[J]. J Clin Sleep Med, 2020, 16(4): 475-482. doi:10.5664/jcsm.8242.
[33] Tokuda F, Sando Y, Matsui H, et al. Serum levels of adipocytokines, adiponectin and leptin, in patients with obstructive sleep apnea syndrome[J]. Intern Med, 2008, 47(21): 1843-1849. doi:10.2169/internalmedicine.47.1035.
[34] Drager LF, Bortolotto LA, Maki-Nunes C, et al. The incremental role of obstructive sleep apnoea on markers of atherosclerosis in patients with metabolic syndrome[J]. Atherosclerosis, 2010, 208(2): 490-495. doi:10.1016/j.atherosclerosis.2009.08.016.
[35] Qian Y, Yi H, Zou J, et al. Independent association between sleep fragmentation and dyslipidemia in patients with obstructive sleep apnea[J]. Sci Rep, 2016, 6: 26089. doi:10.1038/srep26089.
[36] Zhao X, Li X, Xu H, et al. Relationships between cardiometabolic disorders and obstructive sleep apnea: Implications for cardiovascular disease risk[J]. J Clin Hypertens(Greenwich), 2019, 21(2): 280-290. doi:10.1111/jch.13473.
[37] Trenell MI, Ward JA, Yee BJ, et al. Influence of constant positive airway pressure therapy on lipid storage, muscle metabolism and insulin action in obese patients with severe obstructive sleep apnoea syndrome[J]. Diabetes Obes Metab, 2007, 9(5): 679-687. doi:10.1111/j.1463-1326.2006.00649.x.
[38] Steiropoulos P, Tsara V, Nena E, et al. Effect of continuous positive airway pressure treatment on serum cardiovascular risk factors in patients with obstructive sleep apnea-hypopnea syndrome[J]. Chest, 2007, 132(3): 843-851. doi:10.1378/chest.07-0074.
[39] Börgel J, Sanner BM, Bittlinsky A, et al. Obstructive sleep apnoea and its therapy influence high-density lipoprotein cholesterol serum levels[J]. Eur Respir J, 2006, 27(1): 121-127. doi:10.1183/09031936.06.00131304.
[40] Simon B, Gabor B, Barta I, et al. Effect of 5-year continuous positive airway pressure treatment on the lipid profile of patients with obstructive sleep apnea: a pilot study[J]. J Sleep Res, 2020, 29(2): e12874. doi:10.1111/jsr.12874.
[41] Drager LF, Bortolotto LA, Figueiredo AC, et al. Effects of continuous positive airway pressure on early signs of atherosclerosis in obstructive sleep apnea[J]. Am J Respir Crit Care Med, 2007, 176(7): 706-712. doi:10.1164/rccm.200703-500OC.
[42] Comondore VR, Cheema R, Fox J, et al. The impact of CPAP on cardiovascular biomarkers in minimally symptomatic patients with obstructive sleep apnea: a pilot feasibility randomized crossover trial[J]. Lung, 2009, 187(1): 17-22. doi:10.1007/s00408-008-9115-5.
[43] Phillips CL, Yee BJ, Marshall NS, et al. Continuous positive airway pressure reduces postprandial lipidemia in obstructive sleep apnea: a randomized, placebo-controlled crossover trial[J]. Am J Respir Crit Care Med, 2011, 184(3): 355-361. doi:10.1164/rccm.201102-0316OC.
[44] Xu HJ, Yi HL, Guan J, et al. Effect of continuous positive airway pressure on lipid profile in patients with obstructive sleep apnea syndrome: a meta-analysis of randomized controlled trials[J]. Atherosclerosis, 2014, 234(2): 446-453. doi:10.1016/j.atherosclerosis.2014.03.034.
[45] Lin MT, Lin HH, Lee PL, et al. Beneficial effect of continuous positive airway pressure on lipid profiles in obstructive sleep apnea: a meta-analysis[J]. Schlaf Atmung, 2015, 19(3): 809-817. doi:10.1007/s11325-014-1082-x.
[46] 葛晓辉, 王宁宇, 占小俊, 等. 手术对阻塞性睡眠呼吸暂停低通气综合征患者血脂代谢变化的临床观察[J]. 山东大学耳鼻喉眼学报, 2017,31(1): 27-30. doi: 10.6040/j.issn.1673-3770.0.2016.197. GE Xiaohui, WANG Ningyu, ZHAN Xiaojun, et al. Serum lipid changes in obstructive sleep apnea hypopnea syndrome patients underwent airway surgery[J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2017,31(1): 27-30. doi: 10.6040/j.issn.1673-3770.0.2016.197.
[47] Qian YJ, Zou JY, Xu HJ, et al. Association of upper airway surgery and improved cardiovascular biomarkers and risk in OSA[J]. Laryngoscope, 2020, 130(3): 818-824. doi:10.1002/lary.28012.
[1] YUAN Chenyang, LIU Yan, FANG Zhensheng. Advances on the effect of OSAHS on pulmonary function in children [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(1): 143-148.
[2] LÜ Xuqin, WAN Wenjin. Perioperative blood glucose management in patients with obstructive sleep apnea hypopnea syndrome and hyperglycemia [J]. J Otolaryngol Ophthalmol Shandong Univ, 2018, 32(4): 100-104.
[3] . Effects of rosiglitazone on oxidative stress and cognitive function in mice exposed to intermittent hypoxia. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2017, 31(1): 45-49.
[4] GAO Tianxi, XIA Cui, YAN Jing, HOU Jin, KANG Quanqing, WANG Zhenghui, REN Xiaoyong. Analysis of IGF-1 and IGFBP-3 level in liver tissue of rat with intermittent hypoxia. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2016, 30(5): 38-41.
[5] GUAN Lejing, ZHANG Yamei. The effect of obstructive sleep apnea-hypopnea syndrome on pulmonary function of child:a literature review. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2016, 30(5): 75-80.
[6] ZHANG Chan-juan, LI Yan-zhong, WANG Yan. The relationship between brain derived neurotrophic factor and obstructive sleep apnea syndrome [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2015, 29(1): 8-11.
[7] DONG Yi-yuan, LING Yue-fu, ZHANG Yao-ting. Effect of melatonin on the cTnT and Ca2+-ATPase of chronic intermittent hypoxia cardiac muscular tissues [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2014, 28(5): 1-3.
[8] XU Jin-cao, ZHANG Mei-guang, WANG Wei, FENG Yong, LU Ya-yan, JI Yu-bin, GAO Xue. Minimally invasive one-stage multilevel treatment for mild and moderate obstructive sleep apnea hypopnea syndrome in 35 patients [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2014, 28(5): 4-6.
[9] PENG Hao, XU Hui-jie, HUANG Wei-ning, GAO Zhan, HE Yu-xia, HU Chang-yong. Analysis of sound pressure level parameters of snoring sounds in patients with obstructive sleep apnea-hypopnea syndrome and simple snoring [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2014, 28(3): 42-46.
[10] CHEN Xing1, YU Hai-an2, FENG Yong-gang2, ZHU Juan-fen2. Voice acoustic parameters of pre-and post-operation for treating obstructive sleep apnea-hypopnea syndrome in males [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2011, 25(6): 9-.
[11] XU Zhen-Yue, FANG Ming-Da, HONG Bin, LI Zhao-Sheng. Thirty cases of severe OSAHS treated by combination of H-UPPP and low-temperature plasma of the soft palate and corpus linguae [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2009, 23(4): 12-14.
[12] WANG Wei-zhi,WANG Yan,ZHANG Dai-jie . Polysomnography analyses and treatment of obstructive sleep apnea-hypopnea syndrome in senile patients [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2007, 21(6): 518-520 .
[13] WANG Wei-zhi,MA Jian-ling,LIU Jie,ZHANG Dai-jie . Polysomnography of obstructive sleep apnea-hypopnea syndrome in different age persons [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2007, 21(2): 155-157 .
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
[1] HE Shou-huan,CHEN Bin,YIN Shan-kai,SU Kai-ming,JIANG Xiao . Morphological changes of the upper airway in OSAHS patients with UPPP
[J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2008, 22(5): 385 -388 .
[2] SONG Xi-cheng,ZHANG Qing-quan,XIA Yong-hong,LIU Lu-yi, YU Lu-xin,WANG Gao,JIANG Xiu-liang . Post-operative ICU monitoring and nursing for patients with OSAHS[J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2008, 22(5): 389 -392 .
[3] XUE Wei-guo,SUN Jie,JIN Zheng,SHI Wen-bin,XIN Lu,LIN Guo-Jing,LI Jia-yun . [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2006, 20(4): 300 -303 .
[4] ZHANG Qing-quan,LI Xin-min,WANG Qiang,WANG Yong-fu . Some experience of the endoscopy treatment of maxillary sinus lesion with the canine tooth fossa approach[J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2007, 21(1): 38 -39 .
[5] DONG Pin,LI Xiao-yan,TU Li-qiang,MENG Qing-hong,WANG Sang,XIE Jin,JIANG Yan . Reconstruction for advanced hypopharyngeal carcinoma and laryngeal recurrent carcinoma[J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2007, 21(5): 385 -387 .
[6] JIANG Shao-hong,ZHU Yu-hong,WANG Qiang,SONG Xi-cheng . Intractable primary epistaxis: a report of 101 cases[J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2007, 21(6): 542 -544 .
[7] . [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2008, 22(1): 74 -77 .
[8] LEIXun, LIU Qianghe, KONG Zhongyu, XIANG Qiu, GENG WANping, HUANG Hui, DONG Yiyuan, LIU Fangxian. ARelationship between expression of Survivin and radiosensitization effect of EGCG in xenotransplanted nasopharyngeal carcinoma[J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2009, 23(1): 6 -9 .
[9] . [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2009, 23(2): 73 -74 .
[10] . [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2010, 24(01): 29 -33 .
Website Copyright: Editorial Office of Journal of Otolaryngology and Ophthalmology of Shandong University
Address: No.27 Shanda South Road, Jinan, Shandong, China. Post code: 250100 Tel: +86-0531-88366912 Email: ebhxb@sdu.edu.cn Supported by Beijing Magtech Co.Ltd